Clear Search sequence regions


  • acidosis (1)
  • case report (1)
  • diagnosis (1)
  • hyperkalemia (1)
  • hyponatremia (1)
  • infant (2)
  • neonates (1)
  • PHA1 (2)
  • SCNN1A (3)
  • Sizes of these terms reflect their relevance to your search.

    Pseudohypoaldosteronism type 1 (PHA1) is a rare, heterogeneous group of disorders characterized by resistance to aldosterone action. We report the case of a 17-day-old Saudi female infant who presented on the third day of life with persistent hyperkalemia, hyponatremia, and metabolic acidosis. Initial evaluation for congenital adrenal hyperplasia was unremarkable. Genetic testing confirmed a novel homozygous variant (c.1522C>T p.(Arg508) chr 12:6458147 in SCNN1 A) in the SCNN1A gene, consistent with the diagnosis of PHA1B, a genetically confirmed subtype of PHA1. Prompt recognition and management of electrolyte disturbances are crucial in these neonates to prevent life-threatening complications. Copyright © 2024, Alquraishi et al.

    Citation

    Ali Alquraishi, Abdullah Alshahrany, Badriah G Alasmari, Ashwaq Hommadi, Mohammed Alomari. Pseudohypoaldosteronism Type 1b in a Saudi Female Infant Due to Homozygous Variant Gene Mutation in SCNN1A: A Case Report. Cureus. 2024 Aug;16(8):e67165


    PMID: 39295704

    View Full Text